GlaxoSmithKline opened its new $13-million (US) medicinal chemistry laboratory in Singapore in March 2007. The facility is located in the biomedical research hub Biopolis and is part of GSK’s existing Centre for Research in Cognitive and Neurodegenerative Disorders. The laboratory will enable researchers to engage in collaborative biology and chemistry pre-clinical research.
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more!
Printer Friendly Version
Send to a Friend
